ABGs, Metabolic Acidosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Metabolic acidosis occurs when there is an excess accumulation of acid or loss of bicarbonate in the body, leading to decreased blood pH. Common causes include increased production of metabolic acids (e.g., lactic acid in sepsis) or reduced renal elimination of hydrogen ions (e.g., in renal failure).

• Secondary mechanism: The body attempts to compensate through respiratory mechanisms by increasing ventilation to blow off carbon dioxide, thereby reducing carbonic acid levels and partially correcting the pH imbalance.

• Key complication: If the underlying cause is not addressed, severe acidosis can lead to decreased cardiac contractility and arrhythmias, posing significant risks to patient stability.

Patient Profile

Demographics:

45-year-old female, office manager

History:

• Key past medical history: Type 2 diabetes, hypertension, chronic kidney disease stage 3

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Amlodipine 5 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and shortness of breath

• Key symptoms: Nausea, abdominal pain, confusion, decreased urine output

• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.2°C, oxygen saturation 92% on room air

Section 1

As the nursing team continues to monitor the 45-year-old female patient, they observe a change in her status indicative of worsening metabolic acidosis. The patient's respiratory rate has further increased to 28 breaths per minute, and her oxygen saturation has decreased to 88% on room air, prompting the need for supplemental oxygen. Clinically, she appears more lethargic, and her confusion has progressed to disorientation. A repeat set of arterial blood gases (ABGs) reveals a pH of 7.25, bicarbonate (HCO3-) level of 15 mEq/L, and a partial pressure of carbon dioxide (PaCO2) of 30 mmHg. These findings, coupled with the lab results showing elevated serum potassium at 5.8 mEq/L and decreased glomerular filtration rate (GFR) indicating worsening renal function, suggest that the patient’s metabolic acidosis is progressing, likely due to her underlying chronic kidney disease.

The clinical team responds by adjusting the patient’s management plan. They initiate intravenous sodium bicarbonate to help buffer the excess acid and correct the pH imbalance, while continuing to monitor her cardiac rhythm due to the risk of hyperkalemia-induced arrhythmias. Despite these interventions, the patient's blood pressure remains low, now at 90/58 mmHg, indicating possible progression to a state of shock. The interdisciplinary team, including nephrology, is consulted for further evaluation and consideration of renal replacement therapy. As the team collaborates, they must weigh the risks and benefits of potential interventions, considering the patient's comorbid conditions and the need for rapid stabilization to prevent further deterioration.

This change in status requires a reevaluation of the patient's treatment priorities and highlights the need for careful monitoring of her hemodynamic status and renal function. The team must consider the implications of ongoing metabolic disturbances and prepare for potential additional complications, such as electrolyte imbalances and the impact on cardiovascular function, which could further complicate the patient's clinical course.

Section 2

As the team continues to manage the patient's metabolic acidosis, they encounter new complications that demand immediate attention. Despite the administration of intravenous sodium bicarbonate, her arterial blood gases (ABGs) indicate minimal improvement in her acid-base status, with a repeat pH of 7.28, bicarbonate (HCO3-) level of 16 mEq/L, and PaCO2 of 32 mmHg. Her serum potassium remains critically elevated at 6.1 mEq/L, heightening the risk for cardiac arrhythmias. The patient's electrocardiogram (ECG) shows peaked T-waves, a classic sign of hyperkalemia, reinforcing the urgency to address this electrolyte imbalance.

In response to these developments, the clinical team prioritizes interventions to reduce the patient's serum potassium levels. They initiate treatment with intravenous insulin and glucose to facilitate the shift of potassium into the cells, along with inhaled beta-agonists for additional potassium redistribution. Concurrently, they assess the potential need for calcium gluconate to stabilize the cardiac membrane and prevent arrhythmias. Despite these measures, the patient's hemodynamic status remains precarious, with her blood pressure now at 88/56 mmHg, and heart rate elevated at 110 beats per minute, suggesting a compensatory response to maintain perfusion.

The nephrology team evaluates the patient's worsening renal function, with the GFR now critically low, and discusses the feasibility of initiating renal replacement therapy. This decision is made complex by her hemodynamic instability, necessitating a careful balance between urgent intervention and the risk of further destabilization. As the team deliberates, they continue to monitor the patient's fluid status and renal output, aware that any delay in correcting her metabolic disturbances could lead to further deterioration. The multidisciplinary approach remains focused on stabilizing the patient's condition, with an eye on preventing additional complications and preparing for potential escalation in care.

Section 3

As the team continues their vigilant monitoring, the patient's condition evolves, revealing new complications that demand immediate attention. Despite ongoing efforts to correct her metabolic acidosis and hyperkalemia, the patient develops respiratory distress, evidenced by increased work of breathing and a respiratory rate now elevated to 28 breaths per minute. Arterial blood gas analysis shows a further decline in her PaO2 to 68 mmHg, indicating hypoxemia. Crackles are auscultated in the bilateral lung bases, raising concerns for pulmonary edema, likely secondary to both her underlying renal dysfunction and aggressive fluid management.

In light of these findings, the clinical team decides to initiate supplemental oxygen therapy and consider the introduction of non-invasive positive pressure ventilation to assist with her respiratory effort and improve gas exchange. Concurrently, they reassess her fluid balance and contemplate adjusting her diuretics to mitigate the risk of fluid overload. The nephrology team is consulted again to weigh the risks and benefits of initiating dialysis, particularly continuous renal replacement therapy (CRRT), given its suitability for hemodynamically unstable patients.

Despite the intensified interventions, the patient's lab results reveal a rising creatinine level of 3.2 mg/dL and a urine output that has diminished significantly to 15 mL/hr, underscoring the progression of acute kidney injury. The team recognizes the necessity of a delicate balance between addressing her acid-base and electrolyte imbalances while managing her respiratory compromise and preventing further renal deterioration. This complex clinical scenario requires careful prioritization and coordination among the multidisciplinary team to stabilize the patient and prevent cascading organ failures, setting the stage for potentially escalating to advanced supportive measures.

Section 4

As the patient continues to receive supplemental oxygen therapy and non-invasive positive pressure ventilation, her vital signs reveal a mixed picture. Her heart rate remains elevated at 110 beats per minute, and her blood pressure has now dropped to 90/60 mmHg, suggesting a potential compromise in her hemodynamic status. Despite these interventions, her respiratory rate is still elevated at 30 breaths per minute, indicating persistent respiratory distress. The clinical team notes the diminished breath sounds on auscultation and the persistence of crackles in the lung bases, corroborating the suspicion of worsening pulmonary edema.

New laboratory results provide further insights into her deteriorating condition. Her arterial blood gas analysis now shows a pH of 7.25, a further decrease in PaO2 to 65 mmHg, a low bicarbonate level of 16 mEq/L, and a PaCO2 that is beginning to rise at 50 mmHg, signaling a developing respiratory acidosis on top of her metabolic acidosis. The combination of these findings suggests that the patient's compensatory mechanisms are being overwhelmed, possibly due to the cumulative effects of her acute kidney injury and fluid overload. Her serum potassium has decreased slightly to 5.8 mEq/L, but it remains a concern due to the continued risk of cardiac arrhythmias.

In response to these developments, the clinical team decides to escalate the level of care. The nephrology team recommends initiating continuous renal replacement therapy (CRRT) to address her fluid overload and electrolyte imbalances more effectively while supporting her kidney function. Concurrently, the critical care team collaborates to enhance her respiratory support, considering intubation and mechanical ventilation if her respiratory status fails to improve. These strategic interventions aim to stabilize her declining condition, preventing the onset of further complications and facilitating a more comprehensive management plan. As the team prepares to implement these measures, they remain vigilant for any additional signs of organ dysfunction, ready to adapt their approach as needed to optimize her recovery trajectory.

Section 5

As the clinical team implements the recommended interventions, they closely monitor the patient for any changes in her status. Within the first few hours of initiating continuous renal replacement therapy (CRRT), there is a noticeable improvement in her hemodynamic stability. Her blood pressure begins to stabilize, rising to 100/65 mmHg, as the excess fluid is gradually removed. However, despite the stabilization of her circulatory status, her respiratory condition continues to pose significant challenges. The respiratory rate remains elevated at 28 breaths per minute, and her oxygen saturation levels are hovering around 88% on high-flow oxygen, indicating persistent hypoxemia.

The decision to escalate respiratory support is made as her arterial blood gas analysis shows little improvement: her pH remains at 7.28, PaO2 is 68 mmHg, bicarbonate is 18 mEq/L, and PaCO2 has risen slightly to 52 mmHg. These results confirm the persistence of a mixed acid-base disorder, with the respiratory acidosis component becoming more pronounced. In light of these findings, the critical care team proceeds with intubation and mechanical ventilation to reduce her work of breathing and improve gas exchange.

Despite these efforts, a new complication arises: the patient begins to exhibit signs of increasing agitation and confusion, accompanied by a sudden drop in her urine output. Her serum creatinine levels have risen further, now at 3.5 mg/dL, suggesting a worsening of her renal function. The team suspects the possibility of a secondary insult, such as sepsis, contributing to her acute kidney injury and overall clinical deterioration. Blood cultures are drawn, and empiric broad-spectrum antibiotics are initiated to address any underlying infection. This prompts a more comprehensive reassessment of her condition, emphasizing the importance of ongoing vigilance and adaptability in her management plan. As the team grapples with these developments, they remain committed to stabilizing her condition, with a focus on identifying and mitigating any additional sources of organ dysfunction.